Endo, Impax Move To Trim Opana Pay-For-Delay MDL
Pharmaceutical giants Endo and Impax urged an Illinois federal court Friday to partially dismiss state antitrust claims refiled by a putative class of end-payors who allege in multidistrict litigation that the...To view the full article, register now.
Already a subscriber? Click here to view full article